KURA ONCOLOGY, INC. Accounts Receivable, Related Parties, Current
KURA ONCOLOGY, INC. (KURA) had Accounts Receivable, Related Parties, Current of $31.00 thousand as of 2020-03-31, per its 10-Q filed 2020-05-04.
Discontinued › Notes
us-gaap:AccountsReceivableRelatedPartiesCurrent · last filed 2020-05-04
- 2020-03-31: Accounts Receivable, Related Parties, Current $31.00K.
- 2019-12-31: Accounts Receivable, Related Parties, Current $30.00K.
- 2019-09-30: Accounts Receivable, Related Parties, Current $47.00K.
- 2019-06-30: Accounts Receivable, Related Parties, Current $111.00K.
| Period end | Accounts Receivable, Related Parties, Current |
|---|---|
| 2020-03-31 | $31.00K 10-Q · filed 2020-05-04 |
| 2019-12-31 | $30.00K 10-Q · filed 2020-05-04 |
| 2019-09-30 | $47.00K 10-Q · filed 2019-11-05 |
| 2019-06-30 | $111.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $179.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | $224.00K 10-K · filed 2020-02-25 |
| 2018-09-30 | $232.00K 10-Q · filed 2018-11-05 |
| 2018-06-30 | $230.00K 10-Q · filed 2018-08-06 |
| 2018-03-31 | $257.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $216.00K 10-K · filed 2019-03-05 |
| 2017-09-30 | $209.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $304.00K 10-Q · filed 2017-08-07 |
| 2017-03-31 | $341.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $295.00K 10-K · filed 2018-03-12 |
| 2016-09-30 | $261.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $286.00K 10-Q · filed 2016-08-10 |
| 2016-03-31 | $406.00K 10-Q · filed 2016-05-11 |
| 2015-12-31 | $430.00K 10-K · filed 2017-03-14 |
| 2015-09-30 | $379.00K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $372.00K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $349.00K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $30.00K 10-K · filed 2016-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |